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Fleeting Activation of Ionotropic
Glutamate Receptors Sensitizes
Cortical Neurons to Complement Attack
association of soluble plasma proteins with C5b (C6,
C7, C8, and C9) into a multimolecular complex, the mem-
brane attack complex. The membrane attack complex
inserts into and through the membrane, creating a chan-
nel resulting in ion flux and ultimately osmotic lysis (Mor-
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gan, 1999). While its normal function is critical to theDuke University Medical Center and
health of the organism, inappropriate activation of com-4 Durham Veterans Affairs Medical Center
plement can itself damage tissue and contribute to dis-Durham, North Carolina 27710
ease of many organs. Clinical settings in which comple-
ment damages tissues include autoimmune diseases,
such as systemic lupus erythematosus and rheumatoidSummary
arthritis, as well as ischemia-reperfusion injury, which
contributes to damage in myocardial infarction and hyp-Insidious attack of cortical neurons by complement
eracute rejection of transplanted organs (Morgan, 1994,has been implicated in Alzheimer’s and other neurode-
1995; Matis and Rollins, 1995; Asghar and Pasch, 2000).generative diseases. Excitotoxicity, triggered by ex-
To protect against inappropriate activation of comple-cessive activation of glutamate receptors, has been
ment, mammalian cells have evolved an elaborate setimplicated in neuronal death following diverse insults,
of defenses (Liszewski et al., 1996).including ischemia and seizures. Clinical studies sug-
While lagging studies of complement in diseases ofgested that a minimal excitotoxic insult might sensitize
other organs, evidence of inappropriate activation ofneurons to complement attack. We found that fleeting
complement in central nervous system diseases hasactivation of ionotropic glutamate receptors sensi-
recently emerged (Morgan, 1995; Shin et al., 1998;tizes neurons but not astrocytes to complement at-
Gasque et al., 2000). Because the majority of circulatingtack. The complement molecule effecting cytotoxicity
complement proteins are synthesized in the liver andwas the membrane attack complex. The site within
excluded from the brain by the blood-brain barrierthe complement cascade at which sensitization was
(Gasque et al., 2000), complement proteins must eithereffected was the membrane attack pathway. Sensiti-
be synthesized locally in the brain or gain accesszation mediated by glutamate receptor activation re-
through a defective blood-brain barrier. In fact, immuno-quired Ca2o and generation of reactive oxygen spe-
histochemical evidence of complement proteins, includ-cies. These in vitro findings predict that a fleeting
ing the membrane attack complex, have been detectedexcitotoxic insult could act synergistically with com-
in brains of humans with multiple neurodegenerativeplement to destroy cortical neurons and accelerate
diseases, including Alzheimer’s (McGeer et al., 1989;neurological deterioration.
Itagaki et al., 1994; Webster et al., 1997) and Hunting-
ton’s diseases (Singhrao et al., 1999), Rasmussen’s syn-Introduction
drome (Whitney et al., 1999), and multiple sclerosis
(Compston, et al., 1989; Scolding et al., 1989). SelectiveComplement is an important member of the innate im-
inhibition of complement activation exerts beneficial ef-mune system and is a major effector of the humoral
fects in animal models of stroke (Huang et al., 1999) andcomponent of the adaptive immune system (Walport,
multiple sclerosis (Piddlesden et al., 1994; Davoust et2001). Complement consists of more than 30 soluble
al., 1999). While it seems likely that inappropriate activa-
and membrane proteins that interact with one another
tion of complement will contribute to diseases of the
in a tightly regulated manner. The early or “activation”
nervous system in addition to other organs, the mecha-
steps of the complement cascade are analogous to the nisms controlling sensitivity of distinct cellular elements
coagulation system in that precursors of multiple pro- to complement attack are incompletely understood. In
teolytic enzymes (e.g., C1 and C3 in Figure 1) themselves particular, we were struck by the fact that cortical neu-
undergo proteolysis in a sequential and ordered pattern; rons in primary culture are remarkably resistant to com-
enormous amplification results because multiple acti- plement attack (Whitney and McNamara, 2000), leading
vated enzyme molecules are generated by each individ- us to query what might regulate this sensitivity.
ual enzyme molecule. Complement activation can be One mechanism of cellular injury unique to the ner-
triggered by diverse mechanisms, including antibody vous system is excitotoxicity whereby excessive activa-
binding to antigen (classical), by complement proteins tion of ionotropic glutamate receptors can destroy neu-
binding to microbial cell surfaces (alternative), or by rons (Choi, 1988). Evidence from in vitro models and
the binding of serum lectins to mannose residues of multiple animal models have implicated excitotoxicity
microbial proteins (lectin) (Figure 1). Each of the three as a mechanism of neuronal injury following diverse
activation pathways culminates in the enzymatic forma- insults, including ischemia, hypoxia, seizures, trauma,
tion of C5b, the first component of the membrane attack hypoglycemia, and others (Choi, 1988; Doble, 1999).
pathway. Subsequent steps within the membrane attack Clinical studies indicate that fleeting insults thought to
pathway are nonenzymatic and involve the sequential involve excitotoxic mechanisms such as ischemia and
flurries of seizures accelerate the rate of neurological
deterioration in Alzheimer’s disease (Volicer et al., 1995)5 Correspondence: jmc@neuro.duke.edu
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Figure 1. Schematic Overview of the Complement Cascade
The complement cascade can be initiated through three major activation pathways: the classical, alternative, or lectin pathways, each of
which leads to the membrane attack pathway. The classical activation pathway is initiated by binding of the C1 complex to Fc fragments of
antibody-antigen complex to yield the C3 convertase C4b2a, which in turn cleaves C3, leading to formation of the classical pathway C5
convertase C4b2a3b. The classical pathway can be activated by molecules other than antibodies such as A peptide. The lectin pathway is
initiated by binding of mannan binding lectin (MBL) to the mannose groups of microbial carbohydrates. The binding of MBL to mannan binding
lectin-associated serum protease (MASP) forms an enzyme to cleave C4 and C2, leading to formation of C3 convertase C4bC2a, subsequent
steps being identical to the classic pathway. The alternative pathway is activated by binding of low levels of nonenzymatically formed C3b
to bacterial surfaces, leading to formation of the alternative pathway C3 convertase C3bBb and subsequently the alternative pathway C5
convertase C3bBb3b. The three activation pathways converge on the enzymatic cleavage of C5 into C5a and C5b, the latter of which serves
as the initial component of the membrane attack pathway. The subsequent addition of single molecules of C6 and C7 leads to formation of
C5b-7, a minority of which attach to cell membranes. Thereafter, addition of a single C8 and multiple C9 molecules forms C5b-9, the membrane
attack complex (MAC), which creates a transmembrane pore leading to the lysis of the target cell. (Morgan, 1995, 1999).
and Rasmussen’s syndrome (Oguni et al., 1991), dis- addition of LTC acted synergistically with pretreatment
eases in which inappropriate activation of complement with glutamate to destroy cortical cells as evident in an
has been implicated. We therefore queried whether increase of LDH release approximating 300% (compare
fleeting excitotoxic insults might sensitize embryonic third and fourth bars of Figure 2A). The synergistic in-
rat cortical neurons in primary culture to complement crease of cytotoxicity required complement activation
attack. because it was abolished by heat inactivation of the LTC
(56C, 30 min) or by the selective complement inhibitor
sCR1 (200 g/ml; Avant Immunotherapeutics, Need-Results
ham, MA) (Figure 2A). Both glutamate toxicity and sub-
sequent sensitization to complement attack wereExcitotoxic Insults Sensitize Cortical Cells
blocked by coincubation of glutamate with D-APVto Complement Attack
(50 M) or CNQX (50 M), demonstrating that AMPAOur previous studies demonstrated that mixed cortical
and/or NMDA receptor activation were required for thecultures are quite resistant to lysis by normal serum
glutamate-induced sensitization. Selective activation ofcomplement (He et al., 1998; Whitney and McNamara,
NMDA receptors (NMDA, 20M for 5 min in the presence2000). To test whether excitotoxic insults modulate the
of CNQX, 50 M; data not shown) or kainate/AMPAsensitivity of cortical cells to complement attack, cul-
receptors (KA, 100M, 30 min in the presence of D-APV,tures were subjected to a transient (10 min) exposure
50 M; data not shown) produced sensitization similarto a minimally toxic concentration of glutamate (50 M)
to that of glutamate.and subsequently reincubated in glutamate-free me-
While the cytotoxic effects of Low-Tox Complementdium (MEM/D-APV 50 M/CNQX 50 M) with or without
clearly required complement activation in the experi-a sublethal concentration of rabbit complement (lyophi-
ments above, the precise mechanism by which comple-lized Low-Tox Complement; Cedarlane, Ontario, Can-
ment was activated is not clear. We previously demon-ada). In comparison to vehicle, glutamate itself pro-
strated that anti-GluR3 sera destroyed mixed corticalduced modest cell death evident in the100% increase
cultures by a GluR3 antibody-requiring mechanism in-of LDH release measured 24 hr later (compare first and
volving activation of the classical complement pathwaythird bars of Figure 2A). Addition of a low concentration
(He et al., 1998). To determine whether sensitivity to theof Low-Tox Complement (LTC, 1.2 mg/ml) produced no
classical pathway could be enhanced by treatment withdetectable toxicity following vehicle pretreatment (com-
pare first and second bars of Figure 2A). By contrast, an ionotropic glutamate receptor agonist, cultures were
Glutamate Sensitizes Neurons to Complement Attack
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Figure 2. Excitotoxic Insults Sensitize Corti-
cal Cultures to Complement Attack
(A) Mixed cortical cultures were pretreated
with vehicle, glutamate (50 M), or glutamate
(50 M) with D-APV (50 M) or CNQX (50
M) for 10 min followed by exposure to MEM,
Low-Tox Complement (LTC; 1.2 mg/ml), heat-
inactivated LTC (HI-LTC), or LTC with sCR1
(200 g/ml). LDH released into the bathing
medium was assessed after 24 hr of comple-
ment incubation. Values are the means and
SEM of four to eight wells per condition of a
single experiment; each experiment was per-
formed at least three times, and similar re-
sults were obtained. *p  0.001 compared
with glutamate pretreatment followed by
MEM (ANOVA with Student’s t tests).
(B) Trypan blue exclusion assays of mixed
cortical cultures pretreated with vehicle or
glutamate (30 M) for 10 min followed by 3
hr exposure to MEM, LTC, HI-LTC, or LTC
with sCR1. Scale bar, 100 m.
(C) Data presented are averaged counts of
Trypan blue-positive cells from three random
fields per well from four wells. *p  0.001
compared with glutamate pretreatment fol-
lowed by MEM (ANOVA with Student’s t
tests).
(D) Cultures were exposed to increasing con-
centrations of glutamate (1 M to 1 mM) for
10 min followed by LTC or heat-inactivated
LTC. Trypan blue-positive cells per field of
view were counted after 3 hr complement in-
cubation.
(E) Cultures were pretreated with glutamate
(30 M) for 10 min and incubated with in-
creasing concentrations of LTC (0.25–2.00
mg/ml protein) for additional 3 hr.
incubated with AMPA (10 M) or vehicle in the absence followed by either MEM or LTC (Figure 2B, top two
panels; Figure 2C) or when glutamate treatment wasor presence of sera raised by immunization of rabbits
with a GluR3-GST fusion protein (anti-GluR3) (He et al., followed by MEM (Figure 2B, left panel, middle row;
Figure 2C). By contrast, striking increases of cytotoxicity1998), and cell death was monitored by measurement
of LDH in the supernatant 24 hr later. In comparison to evident in many Trypan blue-positive cells occurred
when glutamate pretreatment was followed by incuba-vehicle, AMPA itself produced only modest cell death
evident in the 90% increase of LDH release measured tion in LTC for 3 hr (Figure 2B, right panel, middle row;
Figure 2C). The cytotoxicity mediated by LTC required24 hr later. Addition of a low concentration of anti-GluR3
sera (0.4 mg/ml) alone produced modest toxicity evident activation of complement because it was abolished by
heat inactivation or sCR1 (Figure 2B, bottom two panels;in the70% increase of LDH release. By contrast, coin-
cubation of AMPA and anti-GluR3 acted synergistically Figure 2C).
To further characterize the glutamate-induced sensiti-to destroy cortical cells, as evident in an increase of
LDH release of300% (p 0.001 compared with AMPA zation to complement, cortical cultures were pretreated
with glutamate at concentrations from 1 M to 1 mMalone or anti-GluR3 sera alone). The synergistic increase
of cytotoxicity was abolished by heat inactivation of the for 10 min and subsequently replaced with MEM with
LTC or heat-inactivated LTC. Trypan blue staining wasanti-GluR3 sera. Together these findings demonstrate
that a minimal excitotoxic insult can sensitize cortical performed 3 hr later. The number of Trypan blue-positive
cells was low in cultures pretreated with glutamate upcells to complement attack involving antibody activation
of the classical pathway. to 1 mM followed by heat-inactivated LTC at the 3 hr
time point. In contrast, glutamate potentiated the cyto-To strengthen the conclusion that the increased LDH
release reflected cell death, cytotoxicity was measured toxicity of LTC in a concentration-dependent manner
with an EC50 of 30 M (Figure 2D). To further compareby counting the number of Trypan blue-positive cells
from randomly selected microscope fields by an ob- the sensitivity of cortical cultures to complement-
induced lysis before and after glutamate treatment, cul-server blinded as to treatment. Mixed cortical cultures
were challenged with either vehicle or glutamate (30 M) tures were challenged with increasing concentrations
of LTC after exposure to either vehicle or 30 M gluta-for 10 min and subsequently replaced with MEM with
or without LTC. Following exposure to LTC for 3 hr, cell mate for 10 min. Treatment with complement produced
striking cytotoxicity in a concentration-dependent man-death was examined by Trypan blue staining. Trypan
blue-positive cells were few when vehicle treatment was ner following pretreatment with a minimally toxic con-
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Figure 3. Time Course of Excitotoxin-Mediated Sensitization to Complement Attack
(A) Cultures were pretreated with glutamate (50 M) for 10 min and then incubated with MEM in the presence of 50 M D-APV and CNQX.
LTC or HI-LTC was added at varying time points, including 0, 1, 4, and 12 hr after 10 min glutamate exposure. Following exposure to LTC or
HI-LTC for 24 hr, cell death was assessed by LDH release. LDH release is presented as percent increase over vehicle. Values are the means
and SEM of determinations made in four wells of a single experiment which was repeated three times with similar results. *p  0.05; **p 
0.001 compared with glutamate pretreated cultures followed by heat-inactivated LTC (Glu Pre  HI-LTC).
(B) The data of Figure 2A is presented as the value of (glutamate pretreatment  LTC)  (glutamate pretreatment  HI-LTC) on y axis versus
time on the x axis.
centration of glutamate (Figure 2E), whereas vehicle pre- complement destroys the cells is unclear. Complement
treated cells were remarkably resistant to complement could exert cytotoxic effects through generation of ana-
(Figure 2E). phylatoxins (C3a and C5a), opsonins, and/or the lytic
To examine the time course of the glutamate-medi- membrane attack complex. The availability of rabbit se-
ated sensitization to complement attack, LTC was rum deficient in C6 (C6d; NJC Complement Lab, Denver,
added at varying times after a 10 min exposure to gluta- CO) was used to distinguish the contribution of the early
mate, and cell death was assessed by LDH release 24 activation cascade (anaphylatoxins and opsonins) from
hr thereafter. Following vehicle pretreatment, exposure the membrane attack pathway. Thus, C6d serum pro-
to LTC produced no detectable cytotoxicity at any post- duces C3a and C5a but no terminal complement com-
treatment interval (Figure 3A). However, addition of com- plexes; only when C6d is incubated with C6 can a mem-
plement immediately following the brief treatment with brane attack complex form. In the absence of C6, C6d
glutamate effected a synergistic increase of cytotoxicity was not toxic to cortical cells either with (Figure 4A,
(400% of vehicle) when compared to glutamate pretreat- compare fourth and fifth bars) or without (Figure 4A,
ment alone (200% of vehicle) (p  0.001 compared with compare first and second bars) glutamate pretreatment.
glutamate alone; Figure 3A). The magnitude of the syn- Incubation of C6d with added C6 for 3 hr following vehi-
ergy had diminished from 200% to 80% (Figure 3B) when cle treatment produced small numbers of dead cells
the cells were allowed to recover for 1 hr prior to addition compared to vehicle or C6d alone, as evident in Trypan
of complement (p  0.05 compared with glutamate blue uptake (Figure 4A, compare third bar with the first
alone; Figure 3B), and the synergy had virtually disap- and second bars). By contrast, pretreatment with gluta-
peared with a recovery period of 12 hr (Figures 3A and mate acted synergistically with C6d  C6 to destroy
3B). In subsequent experiments, complement was cortical cells, as evident in an increase in the number
added immediately after preincubation with glutamate of Trypan blue-positive cells of at least 4-fold in compari-
or other agents. son to either glutamate or C6d  C6 alone (compare
Inhibition of complement attack by some complement sixth bar with third or fourth in Figure 4A, p  0.001
regulatory proteins is species restricted (Morgan, 1995, versus glutamate alone or C6d  C6). The cytotoxic
1999; Liszewski et al., 1996). Because the targets of effect of the C6d  C6 required activation of comple-
complement attack in these experiments were cortical ment because it was abolished by coincubation with
cells isolated from rat, we asked whether excitotoxic sCR1 (Figure 4A). Together these data demonstrate that
insults sensitized rat cortical cells to rat complement. the cytotoxic effects of complement require activation
The cytotoxic effects of normal rat sera (Advanced Re- of the membrane attack pathway at some step involving
search Technologies, San Diego, CA) were compared C6 or beyond.
to human and rabbit sera. Similar results were obtained
with sera from all three species. That is, like rabbit and
Excitotoxic Insult Sensitizes Cortical Cellshuman sera, normal rat sera produced no detectable
to Membrane Attack but Not Activation Pathwaycell death in vehicle-pretreated mixed cortical cultures
of the Complement Cascadebut produced striking cytotoxicity in glutamate-pre-
While the results described above demonstrate the ne-treated cultures, effects which were blocked by heat
cessity of the membrane attack pathway for the cyto-inactivation or sCR1 (data not shown).
toxic effects of complement in this paradigm, glutamate
pretreatment could have effected sensitization by en-Complement Toxicity Requires Activation
hancing the activation pathway culminating in C5b de-of Membrane Attack Pathway
position and/or by enhancing responsiveness to theWhile brief exposure to glutamate sensitizes cortical
cells to complement attack, the mechanism by which membrane attack pathway. To determine whether gluta-
Glutamate Sensitizes Neurons to Complement Attack
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Figure 4. Glutamate Pretreatment Sensitizes
Cortical Cells to Membrane Attack but Not
Activation Pathway of Complement Cascade
(A) Complement toxicity requires activation
of membrane attack pathway. Mixed cortical
cultures were exposed to vehicle or gluta-
mate (30 M) for 10 min followed by C6-defi-
cient rabbit serum (C6d, 0.3 mg/ml) either
with or without human C6 (20 g/ml). Trypan
blue-positive cells per field of view were
counted after 3 hr complement incubation.
*p  0.001 compared with vehicle pretreat-
ment followed by C6dC6 or glutamate pre-
treated cultures followed by C6d.
(B) Glutamate pretreatment does not affect
complement activation. Incubation with anti-
GluR3 antibody and human serum enhanced
C3 deposition on cortical cells and sC5b-9
content in culture medium, which were abol-
ished by complement inhibitor sCR1 (200 g/
ml). Glutamate pretreatment did not increase
C3 deposition and sC5b-9 formation.
(C) Glutamate pretreatment sensitizes corti-
cal cells to complement attack. LDH release
was measured from aliquots of culture me-
dium from the experiment described in (B)
above. Glutamate-pretreatment sensitized
cortical cells to complement-mediated cyto-
toxicity.
(D) Excitotoxic insult sensitizes cortical cells
to the membrane attack pathway. Cultures
were exposed to vehicle or glutamate (30M)
for 10 min followed by human C5b6, then C7, C8, and C9, each at 10 g/ml. Trypan blue-positive cells per field of view were counted after
3 hr complement incubation. *p 0.001 compared with vehicle pretreatment followed by C5b6 C7/C8/C9 or glutamate pretreatment followed
by C5b6  C7/C8. Substituting C5 for C5b eliminated the cytotoxicity (data not shown). Values in this figure are the means and SEM of
determinations made in five to eight wells of a single experiment which was repeated three times with similar results.
mate pretreatment enhanced the activation pathway, tion was similar following pretreatment with vehicle or
glutamate (Figure 4B, compare bars seven and eighttwo distinct measures of complement activation were
examined: deposition of C3b on cortical cells and forma- with three and four, respectively); although the activation
pathway was not enhanced compared to vehicle, gluta-tion of soluble C5b-9 in the culture supernatant. Be-
cause C3b deposition is required for formation of C5 mate pretreatment did sensitize the cortical cells to
complement-mediated cytotoxicity (Figure 4C, compareconvertase, the final step in activation for the classical,
alternative, and lectin pathways in which C5b is formed bars two and four). Stated differently, vehicle pretreat-
ment followed by exposure of cortical cells to comple-from C5 (Figure 1), C3b deposition provides a quantita-
tive measure of the early activation pathway. Soluble ment resulted in complement activation but no cytox-
icity; by contrast, glutamate pretreatment followed byC5b-9 also provides a measure of complement activa-
tion. That is, formation of C5 convertase results in the exposure to complement resulted in complement acti-
vation to a similar extent as vehicle but also resultedcatalytic transformation of soluble C5 into C5b, after
which soluble C6, C7, C8, and C9 bind to form a C5b-9 in cytotoxicity. The emergence of cytotoxicity without
differences in the early activation pathway imply thatcomplex either in membrane or solution. Thus, C5b-9
complexes in solution (sC5b-9) provide an additional excitotoxic insults sensitize cortical cells selectively to
the membrane attack pathwaymeasure of complement activation. Importantly, the
C5b-9 in solution is harmless to the cells, whereas C5b-9 To directly test this implication, purified preparations
of each of the proteins of the membrane attack pathwaycomplex formed in the membrane can destroy the cells
(Morgan, 1999). Incubation of cortical cells with anti- were added sequentially following pretreatment with ei-
ther glutamate or vehicle. Pretreatment with glutamateGluR3 antibody and human serum following vehicle
treatment was sufficient to activate complement (Figure but not vehicle exerted striking cytotoxic effects when
followed by the sequential addition of each member of4B, compare bars three and four with one and two,
respectively), as evident in sCR1 inhibitable increases the membrane attack pathway (C5b6; Calbiochem, La
Jolla, CA; C7, C8, and C9; Quidel, Mountain View, CA)of C3b deposition or sC5b-9 formation (Figure 4B, com-
pare bars five and six with three and four, respectively); (compare second and seventh bars of Figure 4D). Pre-
treatment with glutamate followed by addition of eachdespite the complement activation, no cytotoxicity oc-
curred, as evident in lack of increase of LDH release member of the membrane attack pathway resulted in
30 Trypan blue-positive cells per field (Figure 4D, sev-(Figure 4C, compare bars one and two). Pretreatment
with glutamate followed by antiGluR3 antibody and hu- enth bar); each member of the membrane attack path-
way was required because pretreatment with glutamateman serum did not enhance the activation pathway,
because the amount of C3b deposition or sC5b-9 forma- followed by addition of vehicle or C5b6 or C5b6  C7
Neuron
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or C5b6  C7 and C8 (Figure 4D, third, fourth, fifth, number of propidium iodide-stained neurons (Figure 5C,
compare bar seven with bar five, p  0.001) but noand sixth bars) resulted in fewer than five Trypan blue-
positive cells per field. These results demonstrate that change in the number of propidium iodide-stained
astrocytes (Figure 5C, compare bar eight with bar four).glutamate pretreatment sensitizes cortical cells to the
membrane attack pathway of the complement cascade. Stated differently, astrocytes were more sensitive than
neurons to the minimally toxic concentrations of C5b-9In addition, because glutamate pretreatment sensitized
cells to cytotoxicity only when all five proteins (C5b, C6, after pretreatment with vehicle; by contrast, neurons
but not astrocytes exhibited a striking increase in theC7, C8, and C9) of the membrane attack pathway were
added (Figure 4D), these results implicate the membrane sensitivity to the cytotoxic effects of C5b-9 after pre-
treatment with glutamate.attack complex as the effector of cytotoxicity.
To reinforce the evidence that excitotoxic insults se-
lectively sensitized neurons to complement attack, cyto-Excitotoxic Insults Sensitize Neurons but Not
toxicity was examined immunocytochemicaly after 3 hrAstrocytes to Complement Attack
exposure to a sublethal concentration of LTC followingThe mixed cortical cultures used in these experiments
pretreatment with vehicle or glutamate (30 M for 10contain predominantly two types of cells: neurons and
min). Pretreatment with glutamate followed by comple-astrocytes (Whitney and McNamara, 2000). Our previous
ment (LTC for 3 hr) resulted in four times as many propid-studies of these cultures demonstrated that astrocytes
ium iodide-positive neurons per field compared to gluta-are more sensitive to complement attack than neurons
mate followed by MEM (Figure 5D, compare bar sevenfollowing activation of the classical pathway by anti-
with bar five, p  0.001). Only rare propidium iodide-GluR3 IgG (Whitney and McNamara, 2000). To directly
positive astrocytes (less than one per field) were de-test the sensitivity of cultures to the membrane attack
tected under any condition. Together these experimentspathway, mixed cortical cultures were incubated with
demonstrate that a minimal excitotoxic insult sensitizesdifferent concentrations of C5b6, and 15 min later, a
neurons but not astrocytes to complement-mediatedfixed concentration (25g/ml) of each of three remaining
cytotoxicity.members of the membrane attack pathway was sequen-
Because astrocytes in mixed cortical cultures may betially added to the medium. To identify the cells de-
affected even by sublytic concentrations of comple-stroyed by the membrane attack complex, GFAP-immu-
ment, astrocytes might release toxic substances whichnoreactive astrocytes and MAP-2 immunoreactive
could promote the demise of neurons after minimal exci-neurons were counted 3 hr after addition of C5b-9. Dead
totoxic insults. To test this possibility, nominally pureor dying cells were identified by uptake of propidium
neuronal cultures were prepared. Following pretreat-iodide, which was added 30 min prior to fixation. Treat-
ment with vehicle or glutamate (50 M, 10 min), humanment with C5b6 (30 g/ml) followed by addition of C7/
C5b6, C7, and C8/C9 (each at 10 g/ml) were sequen-C8/C9 (each at 25 g/ml) resulted in extensive destruc-
tially added to the nominally pure neuronal cultures.tion of astrocytes, as evident in the GFAP-immunoactive
Pretreatment with glutamate produced minimal cytotox-cells stained with propidium iodide (compare bottom
icity evident by the small increase of propidium iodideright with bottom left panel of Figure 5A); by contrast,
positive-cells (Figures 6A and 6B). Likewise, purifiedonly rare MAP-2 immunoreactive cells stained with pro-
C5b-9 produced negligible cytotoxicity following vehiclepidium iodide (compare top right with top left panel
pretreatment (Figures 6A and 6B). By contrast, gluta-of Figure 5A). Quantitative analyses by an investigator
mate pretreatment followed by sublytic concentrationsblinded as to treatment group confirmed a large number
of C5b-9 produced an5-fold increase in the number ofof propidium iodide-stained GFAP-positive cells (20
propidium iodide-stained neurons (Figure 6B, comparecells per field) compared to occasional propidium io-
bar four with bar three, p  0.001). These data reinforcedide-stained MAP-2-positive cells (approximately two
the conclusion that excitotoxic insults sensitize neuronscells per field) (Figure 5B). Together these findings dem-
to complement attack. The data further support the ideaonstrate that, in the absence of any pretreatments,
that excitotoxic sensitization of neurons to complementastrocytes are much more sensitive than neurons to
attack does not require the presence of astrocytes.toxic concentrations of membrane attack pathway pro-
teins, confirming and extending our previous finding
(Whitney and McNamara, 2000). Calcium Influx and Intracellular Reactive Oxygen
Species Are Required for Excitotoxin-InducedTo determine the cell types destroyed by complement
following sensitization by glutamate, the following ex- Sensitization to Complement
Because calcium influx is necessary for excitotoxicity,periments were performed. In contrast to the high con-
centrations of C5b-9 used in the experiments described we queried whether a calcium-free medium would abol-
ish the sensitization mediated by pretreatment with glu-in the preceding paragraph, cultures were exposed to
a low, minimally toxic concentration of C5b-9 following tamate, NMDA, or kainate. Fleeting exposure of mixed
cortical cultures to low concentrations of glutamate,pretreatment with vehicle or glutamate. Cell death was
assessed 3 hr later by counting immunocytochemically NMDA, or kainate in the presence of 1.8 mM [Ca2o]
resulted in modest amounts of cell death evident inlabeled propidium iodide-stained cells. Following pre-
treatment with vehicle, these low concentrations of increases of LDH approximating 100% above vehicle
alone, an effect attenuated by application of these ago-C5b-9 destroyed a few astrocytes (approximately three
cells per field) but not neurons (Figure 5C). By contrast, nists in nominally calcium-free media (Figure 7A). In the
presence of [Ca2o] (1.8 mM), robust sensitization wasglutamate pretreatment followed by minimally toxic con-
centrations of C5b-9 produced a marked increase in the evident in that treatment with complement compared
Glutamate Sensitizes Neurons to Complement Attack
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Figure 5. Excitotoxins Sensitize Neurons but
Not Astrocytes to Complement-Mediated Cy-
totoxicity
(A) Complement membrane attack pathway
selectively destroys astrocytes in the ab-
sence of glutamate pretreatment. Cultures
exposed to a high concentration of C5b6 (30
g/ml) with C7/C8/C9 (each 25 g/ml) for 3
hr were incubated with propidium iodide (red)
for 30 min, fixed, and immunostained for
MAP-2 or GFAP. Many astrocytes were pro-
pidium iodide positive. Scale bar, 30 m.
(B) The data of Figure 5A is presented as
averaged number of propidium iodide (PI)-
positive cell counts per field from six wells of
a single experiment which was repeated three
times with similar results. *p  0.001 com-
pared with vehicle treatment.
(C) The cultures were pretreated with vehicle
or glutamate (30M) for 10 min, then exposed
to MEM or a low concentration of human
C5b6 (10 g/ml), followed by C7 and then C8
and C9, each at 10 g/ml. In vehicle-pre-
treated cultures, these lower concentrations
of C5b-9 destroyed a modest number of
GFAP-positive astrocytes but fewer than high
concentration of C5b-9; after glutamate treat-
ment, C5b-9 destroyed similar numbers of
GFAP-positive astrocytes but at least 3-fold
more MAP-2-positive neurons. *p  0.001
compared with glutamate pretreatment fol-
lowed by MEM.
(D) Cultures were pretreated with vehicle or
glutamate (30 M) for 10 min, then exposed
to MEM or LTC for 3 hr. GFAP-positive cells
were resistant to complement attack in the
absence or presence of glutamate pretreatment, whereas MAP-2-positive cells were sensitized to complement-mediated cytotoxicity by
glutamate pretreatment. *p  0.001 compared with glutamate pretreatment followed by MEM.
to heat-inactivated complement produced a marked in- free media resulted in no sensitization to complement
attack (Figure 7A).crease of LDH release after pretreatment with glutamate,
NMDA, or kainate (Figure 7A). By contrast, pretreatment Because of our previous demonstration that calcium-
dependent excitotoxicity in this preparation requireswith glutamate, NMDA, or kainate in nominally calcium-
Figure 6. Excitotoxic Sensitization to Complement Cytotoxicity in Cultures Enriched in Cortical Neurons
(A) The cultures were pretreated with vehicle or glutamate (30 M) for 10 min, then exposed to MEM or a low concentration of human C5b6
(10 g/ml), followed by C7 and then C8 and C9, each at 10 g/ml. Cytotoxicity was evaluated 3 hr later by propidium iodide staining (red)
and MAP-2 immunostaining (green). Cortical neurons were resistant to complement attack in the absence of glutamate pretreatment but were
sensitized to complement-mediated cytotoxicity by glutamate pretreatment. Scale bar, 30 m.
(B) Data presented are averaged cell counts per field from six wells of a single experiment which was repeated three times with similar results.
*p  0.001 compared with glutamate pretreatment followed by MEM.
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synthesis of reactive oxygen species (Patel et al., 1996),
we hypothesized that reactive oxygen species were also
required for excitotoxic sensitization to complement at-
tack. To test this hypothesis, we queried whether MnTBAP
would prevent excitotoxic sensitization. MnTBAP, a
metalloporphyrin with SOD mimetic actions, can prevent
excitotoxic cell death in mixed cortical cultures (Patel
et al., 1996), whereas its non-metal containing analog,
TBAP, lacks SOD mimetic actions and is not protective.
Inclusion of MnTBAP (250 M; Calbiochem, La Jolla,
CA) for 30 min prior to and during treatment with gluta-
mate (30 M for 10 min) eliminated the minimal cell
death evident in the approximately five to six Trypan
blue-positive cells per field when studied following a 3
hr incubation in MEM, whereas inclusion of TBAP was
ineffective (Figure 7B). Likewise, inclusion of MnTBAP
(250 M) for 30 min prior to and during treatment with
glutamate eliminated the robust sensitization to comple-
ment-mediated cytotoxicity evident in 50 Trypan blue-
positive cells per field, whereas inclusion of TBAP (250
M) was ineffective (Figure 7B). The elimination of sensi-
tization by MnTBAP but not by TBAP indicated that
reactive oxygen species are necessary for excitotoxic
sensitization.
To determine whether reactive oxygen species are
sufficient to sensitize cortical cells to complement at-
tack, cultures were treated with paraquat, a redox cy-
cling agent capable of generating reactive oxygen spe-
cies intracellularly (Patel et al., 1996), and subsequently
challenged with sublethal concentrations of LTC. Pre-
treatment with paraquat (150 M, in the presence of
D-APV and CNQX, for 6 hr) followed by incubation in
heat-inactivated LTC produced a modest amount of cell
death evident in nine Trypan blue-positive cells per field
compared to less than one Trypan blue-positive cell per
field following pretreatment with vehicle (compare bars
three and one, respectively, in Figure 7C). Likewise, pre-
treatment with paraquat followed by incubation with
Figure 7. Excitotoxic Sensitization Requires [Ca2o] and Generation sublethal concentrations of complement produced a
of Reactive Oxygen Species
striking sensitization to the cytotoxic effects of comple-
In the experiments presented in this figure, values are the means
ment (50 cells per field) when compared either to vehi-and SEM of four to six wells per condition of a single experiment;
cle followed by complement (1 cell per field) or para-each experiment was performed at least three times and similar
quat followed by heat-inactivated complement (9 cellsresults were obtained. (A) Removal of Ca2o during excitotoxin expo-
sure abolished sensitization to complement attack. Mixed cortical per field) (compare bars four, two, and three, respec-
cultures were pretreated with glutamate (30 M), NMDA (20 M), tively, in Figure 7C). Inclusion of MnTBAP for 30 min
or kainate (100M) in 1.8 mM Ca2 medium or 0 added Ca2 medium prior to and during treatment with paraquat eliminated
for indicated times, followed by exposure to Low-Tox Complement paraquat-induced sensitization to complement-medi-
(LTC; 1.2 mg/ml) or heat-inactivated LTC (HI-LTC) in MEM with 50
ated cytotoxicity (data not shown). To determine
M D-APV and 50 M CNQX. (B) Blockade of glutamate-induced
whether any minimally toxic insult would sensitize corti-complement sensitization by reactive oxygen species scavenger,
cal cells to complement attack, cortical cells were prein-MnTBAP. Cortical cultures were pretreated with vehicle or 30 M
glutamate for 10 min in the presence or absence of 250M MnTBAP cubated with staurosporine (0.5 M, in the presence of
or TBAP (present 30 min prior to and throughout the duration of D-APV and CNQX, for 6 hr) followed by incubation in
glutamate treatment), followed by wash and medium change to either complement or heat-inactivated complement.
MEM with heat-inactivated Low-Tox Complement (HI-LTC) or LTC. Pretreatment with staurosporine followed by heat-inac-
Trypan blue staining was performed after 3 hr complement incuba-
tivated complement produced a modest amount of cyto-tion. *p  0.001 compared with glutamate pretreatment followed by
toxicity evident in 20 Trypan blue-positive cells perHI-LTC. (C) Paraquat but not staurosporine also sensitized cortical
field compared to1 Trypan blue-positive cells per fieldcultures to complement attack. Mixed cortical cultures were ex-
posed to vehicle, 150 M paraquat, or 0.5 M staurosporine in the after vehicle pretreatment (compare bar five with bar
presence 50 M D-APV and CNQX for 6 hr, then exposed to HI- one in Figure 7C). Importantly, preincubation with stau-
LTC or LTC for additional 3 hr. *p  0.001 compared with vehicle rosporine did not sensitize cells to complement attack,
pretreatment followed by LTC. because pretreatment with staurosporine produced
similar numbers of Trypan blue-positive cells when sub-
sequently incubated with complement or heat-inacti-
vated complement (compare bars six and five of Figure
Glutamate Sensitizes Neurons to Complement Attack
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Figure 8. Excitotoxic Sensitization Produces
Increased Membrane Attack Complex Immu-
noreactivity in Neuronal Membranes
Cultures enriched in cortical neurons were
pretreated with vehicle or glutamate (50 M)
for 10 min at 37C, washed, and incubated
with C5b-9 for 15 min at 37C. Top panels
show the MAC staining after vehicle (left) and
glutamate (right) pretreatment followed by
C5b-9. The MAC immunoreactivity was spe-
cific in that immunoreactivity was absent in
cultures treated with glutamate followed by
addition of C7/C8/C9 without prior addition
of C5b6 (bottom left); also, immunoreactivity
was eliminated when anti-MAC antibody was
preincubated with sC5b-9 prior to addition to
cultures pretreated with glutamate (bottom
right). Scale bar, 20 m.
7C). Taken together, these results demonstrate that re- agonists sensitized neurons but not astrocytes to com-
plement-mediated cytotoxicity; (3) the molecule ef-active oxygen species are sufficient to sensitize cortical
cells to subsequent attack by complement and that sen- fecting complement-mediated cytotoxicity was the
membrane attack complex; (4) the site within the com-sitization is not simply a nonspecific consequence of
cell stress. plement cascade at which glutamate receptor agonists
sensitized neurons was the membrane attack, not the
activation, pathway; (5) the mechanism by which theExcitotoxic Sensitization Results in Increased
excitotoxic insult sensitized neurons to complement at-MAC Content in Neuronal Membranes
tack required Ca2o and reactive oxygen species.Precisely how excitotoxic insults sensitize cortical neu-
rons to complement attack is incompletely understood.
One possibility is that equivalent MACs are inserted into Minimal Excitotoxic Insult Sensitized Cortical
neuronal membranes, but an excitotoxic insult cripples Neurons to Complement Attack
the neuron’s ability to restore ionic imbalances and re- A fleeting exposure to glutamate produced a striking
sist osmotic lysis. Alternatively, an excitotoxic insult may increase in the sensitivity of cortical cells to the cytotoxic
somehow result in increased numbers of MACs present effects of complement. The sensitizing effects of gluta-
in the neuronal membrane. To distinguish these possibil- mate as well as the cytotoxic effects of complement
ities, the presence of MACs in neuronal membranes was were concentration dependent. The sensitization is me-
assessed immunocytochemically following treatment of diated by activation of ionotropic glutamate receptors,
cultures enriched in cortical neurons with either vehicle because the glutamate effect can be inhibited by coincu-
or glutamate. Following pretreatment with vehicle or 50 bation with AMPA/KA and NMDA receptor antagonists;
M glutamate for 10 min, cultures were sequentially moreover, activation of either NMDA or AMPA/KA recep-
exposed to human C5b6 (10 g/ml) followed by C7 (10 tors alone is sufficient to produce sensitization as evi-
g/ml). After 5 min incubation at 37C, the cultures were dent in the effects of the selective agonists of these
washed, and C8 and C9 (each at 10 g/ml) were added respective receptors. When tested alone, the concentra-
for an additional 15 min at 37C; following wash in cold tions of glutamate required to effect sensitization pro-
buffer, an additional incubation with a MAC-specific an- duced minimal cytotoxic effects; a striking synergy was
tibody (Calbiochem) was performed at 4C for 20 min evident when the cultures were sequentially exposed to
followed by washing, fixation, and addition of secondary an otherwise sublethal concentration of complement.
antibody. Pretreatment with glutamate produced exten- The effects of sensitization were not merely quantita-
sive MAC immunoreactivity on neuronal processes in tive in the sense of simply increasing the potency of
comparison to vehicle-treated controls (Figure 8). complement; rather, glutamate pretreatment trans-
formed neurons from a complement-resistant to a com-
plement-sensitive cell type without altering the sensitiv-Discussion
ity of astrocytes. Our previous work demonstrated that
anti-GluR3 antisera destroyed cortical cells by activat-The principal findings of this study are 5-fold: (1) fleeting
exposure of mixed cortical cultures to minimally toxic ing the classical complement pathway in a GluR3 anti-
body requiring manner (He et al., 1998); oddly, althoughconcentrations of ionotropic glutamate receptor ago-
nists produced striking increases in sensitivity to the the expression of GluR3 in neurons greatly exceeded
that of astrocytes, astrocytes were far more sensitive tocytotoxic effects of complement; (2) glutamate receptor
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complement attack by anti-GluR3 antisera than neurons cies, which is critical to excitotoxic death of neurons
(Lafon-Cazal et al., 1993; Ciani et al., 1996; Dugan et al.,(Whitney and McNamara, 2000). We demonstrated that
increased expression of the complement regulatory pro- 1995; Patel et al., 1996; Li et al., 2001; Vergun et al.,
2001). Here we extend these earlier findings and demon-tein CD59 in neurons compared to astrocytes contrib-
uted to their differential sensitivity to complement attack strate that reactive oxygen species also mediate excito-
toxic sensitization of neurons to complement attack as(Whitney and McNamara, 2000). Our present results con-
firm and extend these findings by demonstrating that evident in three findings. (1) Exposure to paraquat, a
compound that increases intracellular reactive oxygendirect application of high concentrations of purified pro-
teins of the membrane attack pathway preferentially de- species, was sufficient to induce sensitization to com-
plement. (2) Paraquat-mediated sensitization to comple-stroy astrocytes compared to neurons as evident in the
disappearance of GFAP but not MAP-2 immunoreactive ment was abolished by the superoxide dismutase mimic
MnTBAP but not TBAP. (3) Excitotoxin-induced sensiti-cells after exposure to C5b-9 following vehicle pretreat-
ment. By contrast, pretreatment with glutamate followed zation to complement was abolished by coincubation
of glutamate receptor agonists with MnTBAP but notby application of low concentrations of purified proteins
of the membrane attack pathway enhanced the destruc- TBAP. Together with our earlier evidence that paraquat
and excitotoxins induce formation of reactive oxygention of MAP-2 but not GFAP immunoreactive cells, dem-
onstrating that sensitization increased the susceptibility species under these conditions, these findings implicate
excitotoxin-induced reactive oxygen species as a criti-of neurons to complement attack without modifying the
susceptibility of astrocytes. Because the sensitizing ef- cal mediator of sensitization to complement attack.
How might excitotoxin-induced reactive oxygen spe-fects of glutamate pretreatment are mediated by iono-
tropic glutamate receptors, the selective sensitization cies sensitize neurons to complement attack? Elucidat-
ing the site within the complement cascade at whichof neurons is likely due, at least in part, to the enriched
expression of ionotropic glutamate receptors on neu- glutamate pretreatment effects sensitization is neces-
sary to answer this question. Glutamate pretreatmentrons. The fact that sensitization can be induced in cul-
tures selectively enriched in cortical neurons indicates did not enhance the activation pathway as measured
by C3b deposition or sC5b-9 formation but rather en-that astrocytes are not required for sensitization; it
seems plausible that an event intrinsic to the neuron hanced sensitivity to the membrane attack pathway. The
immunocytochemical experiments demonstrated in-undergoing glutamate receptor activation mediates the
sensitization. creased content of membrane attack complexes on
neuronal membranes following an excitotoxic insult.Complement can exert cytotoxic effects by diverse
mechanisms, raising the question as to which step in Whether this reflects enhanced deposition and/or re-
duced elimination of membrane attack complexes fromthe complement cascade effected cytotoxicity following
sensitization. The emergence of robust cytotoxicity only the neuronal membrane is uncertain. Regardless, the
increased membrane attack complex content in the neu-when C6 was added to the C6-deficient sera following
glutamate exposure demonstrated that the membrane ronal membranes would be expected to collapse elec-
trochemical gradients and destroy ionic homeostasis,attack pathway was necessary for cytotoxicity following
sensitization. Indeed formation of the membrane attack resulting in osmotic lysis of the neuron (Mayer, 1972).
Precisely how reactive oxygen species result in in-complex in particular effects cytotoxicity because cyto-
toxicity occurred only when all five purified proteins of creased membrane attack complex content in the neu-
ronal membrane is under investigation.the membrane attack pathway were added following
glutamate pretreatment.
Excitotoxicity, Complement,
and NeurodegenerationReactive Oxygen Species: A Molecular Link
between Excitotoxicity and Neuronal The present in vitro findings suggest that the simultane-
ous occurrence of excitotoxic and complement insultsSensitization to Complement Attack
The present findings establish reactive oxygen species in vivo could act synergistically to destroy cortical neu-
rons. The human brain appears to be subject to aas a critical molecular link between excitotoxic insults
and sensitization of neurons to complement attack. Us- chronic, low-level attack by complement in multiple neu-
rodegenerative diseases in which complement proteinsing conditions as in the present experiments, we pre-
viously demonstrated that excitotoxic concentrations of are synthesized locally within the brain (Morgan, 1994;
Shin et al., 1998; Gasque et al., 2000). In particular,either NMDA or KA induced the synthesis of reactive
oxygen species as detected by the selective and revers- evidence of membrane attack complex immunoreactiv-
ity decorating cortical neurons has been identified inible inactivation of aconitase (Patel et al., 1996); pretreat-
ment of the cultures with the superoxide dismutase mi- autopsy specimens of Alzheimer’s disease (McGeer et
al., 1989; Itagaki et al., 1994; Webster et al., 1997); activa-metic MnTBAP prevented both the excitotoxin-induced
inactivation of aconitase and the associated cell death. tion of the classical complement cascade by A peptide
in vitro (Jiang et al., 1994) suggests that excessive depo-Likewise, we previously demonstrated that treatment
with paraquat resulted in aconitase inactivation and cell sition of this peptide extracellularly serves to activate
complement, a necessary step to set the stage for thedeath, each of which was prevented by pretreatment
with MnTBAP (Patel et al., 1996). These findings were deleterious effects of an excitotoxic insult sensitizing
neurons to the membrane attack pathway of comple-reinforced by work from multiple laboratories using a
diversity of methods, the consensus being that excito- ment. Immunohistochemical evidence of IgG and mem-
brane attack complex on cortical neurons has also beentoxic insults induce formation of reactive oxygen spe-
Glutamate Sensitizes Neurons to Complement Attack
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from day 18 embryos, trypsinized, dissociated by trituration, andidentified in Rasmussen’s encephalitis (Whitney et al.,
plated onto poly-L-lysine (1 mg/ml)-coated glass coverslips (200,0001999) in which IgG directed against cortical neurons is
cells/coverslip) for 4 hr in plating medium. The coverslips were thenpostulated to activate complement; here focal disrup-
transferred to 12-well plates containing a monolayer of cortical glial
tions of the blood-brain barrier are postulated to provide cells in culture medium (Neurobasal media with 2% B27 supplement,
access of complement proteins leading to complement 1% GlutaMAX I, and 1 g/ml gentamicin). Cytosine arabinofurano-
side (final concentration 5 M; Sigma) was added to the culturesactivation.
for 3 days to suppress glial growth at which time the medium wasThe present findings support the idea that the occur-
replaced. Subsequently, the medium was partially replaced twice arence of a fleeting minimal excitotoxic insult in the con-
week. Experiments were performed after 9–14 days in vitro, usingtext of sustained but sublethal complement activation
individual coverslips transferred to a second 12-well plate devoid
could destroy cortical neurons. Excitotoxicity has been of glia. At this time,99% of the cells were neurons as assessed by
widely implicated as a mechanism of neuronal death immunocytochemistry for microtubule-associated protein 2 (MAP-2)
and glial-fribrillary acidic protein (GFAP) (data not shown); thesein animal models of diverse insults, including transient
cultures will thus be referred to as “nominally pure neuronal cul-ischemia, hypoxia, hypoglycemia, flurries of seizures,
tures.”and trauma (Choi, 1988; Doble, 1999). Thus, it seems
plausible that a transient ischemic attack or a flurry of
seizures occurring in a patient with Alzheimer’s disease Production of Anti-GR3 Sera
Anti-GR3 sera were prepared as described previously (He et al.,could transform a sublethal into a devastating attack by
1998).complement. In accord with this idea, Volicer et al. (1995)
observed more rapid deterioration of dementia in pa-
tients with the clinical diagnosis of Alzheimer’s in a sub- Neurotoxicity Assays
On the day of the experiment, cultures were incubated with gluta-group with seizures compared to a subgroup without
mate in MEM for 10 min or kainate in MEM containing 50 M D-APVseizures. Likewise, a systematic analysis of the Roches-
(Tocris Cookson) for 30 min or NMDA in Ca2- and Mg2-free HBSSter, MN, population (Kokmen et al., 1996) disclosed that
supplemented with 1.8 mM CaCl2, 10 mM HEPES, and 5 M glycinethe occurrence of a stroke conferred an increased risk for 5 min at 37C . Exposure was terminated by two washes with
for development of dementia due to Alzheimer’s disease MEM containing 50 M D-APV and 50 M CNQX and replaced with
MEM containing 50 M D-APV and 50 M CNQX with or without(as distinct from multi-infarct dementia), with the onset
complement. The cultures were returned to the incubator for anof Alzheimer’s disease typically beginning shortly after
additional 3–24 hr.the stroke. Analyses of the clinical course of children
Cell death was assessed by measuring lactate dehydrogenasewith Rasmussen’s encephalitis (Oguni et al., 1991) dis-
(LDH) activity in culture supernatants by a spectrophotometric
closed that neurological function often deteriorated method (Whitney and McNamara, 2000). In additional experiments,
abruptly in association with flurries of seizures rather cell death was assessed by uptake of 0.4% Trypan blue dye. In other
experiments, propidium iodide was added to a final concentration ofthan insidiously over time. While multiple factors might
5 g/ml 30 min before the end of the experiment to label dying cells.contribute to the clinical correlations noted here, excito-
Data are presented as the means and SEM of determinations madetoxic sensitization to complement attack may be one
in four to eight wells per condition of a representative experiment.mechanism by which seizures or ischemia accelerate
Each experiment was performed at least three times. Statistical
neurological deterioration in these neurodegenerative analysis consisted of analysis of variance (ANOVA), followed by
diseases. If excitotoxic sensitization to complement at- post-hoc Student’s t tests.
tack proves to be a common mechanism promoting
deterioration in multiple neurodegenerative diseases,
C3 and sC5b-9 ELISA
pharmacological inhibition of the complement mem- Mixed cortical cultures were treated with vehicle or 50M glutamate
brane attack pathway may prove to be a clinically feasi- for 15 min. Following treatment, cultures were incubated with anti-
GluR3 antisera (heat-inactivated rabbit anti-GluR3 sera) and humanble approach for reducing the rate of neurological deteri-
serum for 3 hr at 37C, washed, and fixed. C3 deposition was thenoration in diverse diseases of the human nervous system
measured by a C3-specific ELISA (HRP-anti-human C3; Cappel).(Morgan, 1994; Shin et al., 1998; Gasque et al., 2000).
Absorbance was read at 405 nm. Aliquots of culture medium from
the experiment described above were removed at 3 hr, and sC5b-9
Experimental Procedures content was measured with a sC5b-9-specific ELISA kit (Quidel).
Primary Cortical Cultures
Mixed cortical cultures, containing both neurons and astrocytes, Immunocytochemistry
MAP-2 and GAFP immunocytochemistry were performed as de-were prepared as described (He et al., 1998). Briefly, the cerebral
cortices from day 18 rat embryos (Sprague-Dawley, Zivic Miller) scribed previously (Whitney and McNamara, 2000). To detect mem-
brane attack complexes, following application of various comple-were dissected and enzymatically dissociated with Ca2- and Mg2-
free Hank’s balanced salts solution (HBSS) supplemented with 10 ment proteins to neuronal enriched cultures, the cultures were
washed three times with cold phosphate-buffered saline (PBS) andmM HEPES and 2.5 mg/ml trypsin in HBSS for 20 min at 37C. After
rinsing with HBSS and washing in plating media (minimal essential incubated with rabbit anti-human C5b-9 (Calbiochem, La Jolla, CA)
for 20 min at 4C. Subsequently, cultures were washed and fixedmedium [MEM] supplemented with 3 mg/ml glucose, 5% fetal bovine
serum, and 5% horse serum; all from Life Technologies) containing for 10 min in 4% paraformaldehyde in 0.1 M phosphate buffer, pH
7.4. After three washes in PBS, cultures were incubated for 30 min10 g/ml DNase (Life Technologies, Rockville, MD), the tissue was
triturated through a fire-polished Pasteur pipette. After centrifuga- in 1.5 g/ml biotinylated goat anti-rabbit IgG (Jackson ImmunoRe-
search Laboratories, West Grove, PA) diluted in blocking buffer (PBStion and resuspension, cells were plated at 860,000 cells/ml in 90
l/well in 96-well plates or 500 l/well in 24-well plates in plating containing 5% goat serum). To visualize biotinylated secondary anti-
bodies, cultures were washed three times in PBS followed by amedia. Cultures were maintained at 37C in 5% CO2-95% O2 in a
humidified incubator until used for experiments on 14–16 days in 15 min incubation with streptavidin-linked Oregon Green (4 g/ml,
Molecular Probes, Eugene, OR) in PBS. After three washes, culturesvitro.
In some experiments, cultures selectively enriched in rat cortical were dried, mounted in Vectashield (Vector Laboratories, Burl-
ingame, CA), and viewed with a fluorescent microscope.neurons were used. To prepare these cultures, cortex was removed
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